TNFRSF1A and Insulin resistance: Indeed, anti-TNFR1 treatment significantly (p < 0.05) improved insulin resistance [HOMA-IR 5.7 ± 0.5 (TNFR1-Ab) vs. 9.1 ± 1.6 (control-Ab); Fig. 4c].